Juan Sierra‐Madero

A Controlled Trial of Valganciclovir as Induction Therapy for Cytomegalovirus Retinitis

Daniel Martín, Juan Sierra‐Madero, Sharon Walmsley et al. · New England Journal of Medicine · 2002 · 394 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double-blind, placebo-controlled clinical trial

Gustavo Reyes‐Terán, Juan Sierra‐Madero, Veronica Martínez del Cerro et al. · AIDS · 1996 · 198 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients

Velia Ramírez‐Amador, Lilly Esquivel‐Pedraza, Juan Sierra‐Madero et al. · Medicine · 2003 · 139 citations

Dentistry, Oral Medicine, Oral Pathology +17

Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study

Catherine Orrell, Debbie Hagins, Elena Belonosova et al. · The Lancet HIV · 2017 · 118 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, Laura E. Hernández‐Vanegas et al. · Clinical Immunology · 2021 · 116 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +12